Skip to main content
Date: November 7th-8th
Location: Berlin, Germany
View event website
sphere fluidics logo

Join us at CellME, Berlin where Field Application Scientist, Tarun Kumar Mahto will be presenting:


Novel automated picodroplet-based technology to streamline cell line development and cell engineering workflows


Generation of a highly expressing, regulatory acceptable clonal cell line is the first key step in the development of a biopharmaceutical. To provide the key characteristics (Productivity, Stability, Quality, Monoclonality, and Scalability) from a cell line is challenging especially when using traditional techniques. Significant bottlenecks develop when screening for these rare cells and lengthen the cell line development workflows.  Similarly, cell engineering strategies for biotherapeutics discovery frequently add costs and time. Our Cyto-Mine® platform, powered by picodroplet-based microfluidic technology, streamlines the cell line development workflow. It offers a powerful solution to the challenges of screening large numbers of cells allowing isolation of the highest value clones while ensuring monoclonality and enables a viable high-throughput cell engineering workflow.

Date & Time: 

7th November, 14:30pm


We’ll see you at Booth #1922!

news icon

Join our mailing list for updates

Receive latest updates from Sphere Fluidics about new products, special offers and events

You may also like